The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial


Austin, Gemma M, Knight, Katy, Bell, Joanne, Carter, Anthony, Heartin, Earnest, Watson, David, Foroni, Letizia, Christmas, Stephen E, Polydoros, Fotios and Clark, Richard E ORCID: 0000-0002-1261-3299 (2019) The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial. BRITISH JOURNAL OF HAEMATOLOGY, 185 (4). pp. 791-793. ISSN 0007-1048, 1365-2141

[thumbnail of paper177 ImmunoDESTINY letter to BJH Aug 9th.docx] Text
paper177 ImmunoDESTINY letter to BJH Aug 9th.docx - Author Accepted Manuscript
Download (51kB)
Item Type: Article
Uncontrolled Keywords: chronic myeloid leukaemia, treatment discontinuation, lymphocyte subsets, tyrosine kinase inhibitors, imatinib
Depositing User: Symplectic Admin
Date Deposited: 19 Nov 2018 10:39
Last Modified: 07 Dec 2024 05:48
DOI: 10.1111/bjh.15629
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3028927
Altmetric
Share
CORE (COnnecting REpositories)